Addus HomeCare Corporation (ADUS)
ADUS trades on Nasdaq in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1468328/000143774926005352/0001437749-26-005352-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | ADUS on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Country | United States |
| IPO year | 2009 |
| SEC CIK | 0001468328 |
| SEC industry code | Services-Home Health Care Services |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.4B |
| Net income | $95.9M |
| Operating income | $138.6M |
| Net margin | 6.7% |
| Operating margin | 9.7% |
| Revenue growth | +23.2% |
| Cash | $81.6M |
| Total assets | $1.4B |
| P/E (computed) | 24.2× |
| P/S (computed) | 1.6× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-04 |
| Cash and burn | $98.5M cash; operating cash flow $38.0M a quarter. | Report 2026-09-30 |
| Shares outstanding | 18,633,316 (2026-10-28); 18,483,271 a year earlier; 16,214,653 three years earlier. | Cover page 2026-10-28 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers LLP, Dallas, Texas, United States | PCAOB Form AP 2026-03-05 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $5.3M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $387.7M | $28.6M | $40.9M | $98.5M | $21.9M | $1.5B | 10-Q 2026-11-04 |
| Q2 2026 2026-06-30 | $377.4M | $27.6M | $40.0M | $99.6M | $61.6M | $1.5B | 10-Q 2026-08-04 |
| Q1 2026 2026-03-31 | $363.6M | $25.1M | $52.4M | $103.1M | $91.3M | $1.4B | 10-Q 2026-05-05 |
| Q4 2025 2025-12-31 | $373.1M | $29.8M | $18.8M | $81.6M | $121.0M | $1.4B | 10-K 2026-02-24 |
| Q3 2025 2025-09-30 | $362.3M | $22.8M | $51.3M | $101.9M | $150.6M | $1.3B | 10-Q 2026-11-04 |
| Q2 2025 2025-06-30 | $349.4M | $22.1M | $22.5M | $91.2M | $169.1M | $1.3B | 10-Q 2026-08-04 |
| Q1 2025 2025-03-31 | $337.7M | $21.2M | $18.9M | $97.0M | $198.7M | $1.2B | 10-Q 2026-05-05 |
| Q4 2024 2024-12-31 | $297.1M | $19.5M | $10.4M | $98.9M | $218.4M | $1.2B | 10-K 2026-02-24 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-3ASR | S-3ASR | 2025-08-27 |
| Latest annual report FORM 10-K/A | 10-K/A | 2026-03-12 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-11-04 |
| Latest current report FORM 8-K | 8-K | 2026-11-03 |
| Latest proxy FORM DEF 14A | DEF 14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 984 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -1.1% |
| 1 month | +7.4% |
| 3 months | +4.6% |
| Year to date | +14.5% |
| 1 year | +11.0% |
| From 52-week high | -3.9% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Nursing Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AVAH | Aveanna Healthcare Holdings Inc. | $11.63 | +1.13% | $2.5B |
| PRVA | Privia Health Group Inc. | $25.26 | +2.89% | $3.2B |
| TDOC | Teladoc Health Inc. | $8.70 | -1.14% | $1.6B |
| WGS | GeneDx Holdings Corp. | $51.02 | -2.58% | $1.5B |
| USPH | U.S. Physical Therapy Inc. | $99.55 | +0.41% | $1.5B |
| INNV | InnovAge Holding Corp. | $9.58 | +1.16% | $1.3B |
| PNTG | The Pennant Group Inc. Common Stock | $37.03 | +2.66% | $1.3B |
| HIMS | Hims & Hers Health Inc. | $18.56 | -5.93% | $4.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier